Ravi Salgia to Receptor, EphA2
This is a "connection" page, showing publications Ravi Salgia has written about Receptor, EphA2.
Connection Strength
0.375
-
EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation. J Biol Chem. 2010 Jun 11; 285(24):18575-85.
Score: 0.375